Principle Investigator of the Alzheimer's Disease, Neuroimaging Initiative, Professor in Residence, Medicine, Psychiatry, and Neurology, University of California, San FranciscoBiography
Michael Weiner, MD, is a Professor in Residence in Radiology and Biomedical Engineering, Medicine, Psychiatry, and Neurology at the University of California, San Francisco. He is Principle Investigator of the Alzheimer's Disease Neuroimaging Initiative, which is the largest observational study in the world concerning Alzheimer's Disease. He is the former Director of the Center for Imaging of Neurodegenerative Diseases (CIND) at the San Francisco Veterans Affairs Medical Center. After graduating from the Johns Hopkins University in 1961, He obtained his M.D, from SUNY Upstate Medical Center in Syracuse, New York in 1965, and he completed his internship and residency in Medicine from Mt. Sinai Hospital in 1967. From 1967-1968, Dr. Weiner completed a residency and clinical fellowship in Metabolism from Yale-New Haven Medical Center. In 1970, he completed a research fellowship in Nephrology from Yale University School of Medicine and a research fellowship in Biochemistry from the University of Wisconsin Institute for Enzyme Research in 1972, followed by a joint appointment in the Department of Medicine, Renal Section from the University of Wisconsin Institute in 1972. In 1974 he became an Assistant Professor of Medicine (Nephrology) at Stanford University, and in 1980 he became an Associate Professor of Medicine (Nephrology) at UCSF. In 1983, he established the Magnetic Resonance Unit at the San Francisco VA Medical Center, which became the Center for Imaging of Neurodegenerative Diseases in 2000. In 1990, he became a Professor of Radiology, Medicine, Psychiatry and Neurology at UCSF. During the past 25 years he has worked to develop and optimized the use of MRI, PET, and blood based biomarker methods to diagnose Alzheimers disease and other neurodegenerative disorders. Also, Dr. Weiners research focuses on monitoring effects of treatment to slow progressions in Alzheimers disease, and detecting Alzheimers disease early in patients who are not demented, but risk subsequent development of dementia. He is the Principle Investigator of the Alzheimers Disease Neuroimaging Initiative which has enrolled over 1500 subjects (including controls, MCI, and AD) at 68 sites across the USA and Canada for cognitive testing, MRI, PET, and lumbar puncture. He has also launched The Brain Initiative, which is a web-based registry for recruiting, screening, and longitudinally monitoring subjects for neuroscience studies of all types. Dr. Weiner has 649 published articles and he has written 70 book chapters.